Return to homepagePandemic Pact

Development of a Sublingual COVID-19 Subunit Vaccine

Grant number: RF-TAA-2022-V01

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $410,503.29

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Eunyoung Chun

  • Research Location

    Switzerland, 41

  • Lead Research Institution

    CHA Vaccine Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of a sublingual COVID-19 vaccine combined with a proprietary adjuvant L-pampo ™. This study includes formulation of the sublingual vaccine and evaluation of immunogenicity and efficacy.